• What are the indications for Taletrectinib

  IBTROZI (Taletrectinib) is a kinase inhibitor used to treat locally advanced or metastatic ROS1 positive non-small cell lung cancer.1. IndicationsIBTR···【Read More】

  Update: 2026-09-29Source: Haiou HealthViews: 86

• What are the efficacy and effects of Sunvozertinib

  Sunvozertinib is an oral, irreversible EGFR tyrosine kinase inhibitor (TKI) primarily used to treat locally advanced or metastatic non-small cell lung···【Read More】

  Update: 2026-09-28Source: Haiou HealthViews: 91

• How long does it take for Sunvozertinib to be effective

  Shuvotinib usually needs to be taken continuously for a period of time to show efficacy. The specific duration of treatment may vary depending on indi···【Read More】

  Update: 2026-09-28Source: Haiou HealthViews: 90

• Sunvozertinib is a targeted drug of several generations

  Shuvotinib is often broadly classified as a "third-generation" EGFR targeted drug, but strictly speaking, it is a novel highly selective EGF···【Read More】

  Update: 2026-09-28Source: Haiou HealthViews: 89

• Precautions for the use of Gumetinib

  Gumetinib is an oral MET inhibitor used for locally advanced or metastatic non-small cell lung cancer with MET14 exon skipping mutations. The standard···【Read More】

  Update: 2026-09-24Source: Haiou HealthViews: 85

• Usage and dosage of Gumetinib

  Gumetinib is an oral MET inhibitor used for locally advanced or metastatic non-small cell lung cancer with MET14 exon skipping mutations. The standard···【Read More】

  Update: 2026-09-24Source: Haiou HealthViews: 92

• What generation of targeted drugs is Glumetinib

  Gumetinib does not belong to the traditional "first generation" or "third generation" targeted drug generation system, and it is u···【Read More】

  Update: 2026-09-24Source: Haiou HealthViews: 87

• Medication instructions for Savolitinib

  Basic knowledge of SavolitinibSevotinib is a potent and highly selective oral MET tyrosine kinase inhibitor that exhibits clinical activity in advance···【Read More】

  Update: 2026-09-23Source: Haiou HealthViews: 94

• What are the basic knowledge of Savolitinib drugs

  indicationUsed for the treatment of locally advanced or metastatic non-small cell lung cancer patients with MET exon 14 jump mutation positivityeffect···【Read More】

  Update: 2026-09-23Source: Haiou HealthViews: 97

• What is Orelabrutinib

  indication1、 Adult patients with mantle cell lymphoma (MCL) who have received at least one treatment in the past.2、 Adult patients with chronic lympho···【Read More】

  Update: 2026-09-23Source: Haiou HealthViews: 96

• Is Pyrotinib a Chemotherapy Drug or a Targeted Therapy?

  Pyrotinib is a targeted therapy, not a chemotherapy drug. It belongs to the class of small-molecule tyrosine kinase inhibitors (TKIs) and works by pre···【Read More】

  Update: 2026-09-22Source: Haiou HealthViews: 97

• Overview of Pyrotinib

  Pyrotinib is a small-molecule tyrosine kinase inhibitor (TKI) targeting HER2-positive breast cancer. It inhibits tumor growth by blocking the HER2 sig···【Read More】

  Update: 2026-09-22Source: Haiou HealthViews: 93

• Dosage and Administration of Anlotinib

  The standard dosage of Anlotinib is 12 mg orally once daily before breakfast, administered in a regimen of "2 weeks on treatment followed by 1 we···【Read More】

  Update: 2026-09-21Source: Haiou HealthViews: 94

• Dosage and Administration of Ensartinib

  The standard dosage of Ensartinib is 225 mg orally once daily, with or without food, swallowed whole at a fixed time every day. Treatment does not sta···【Read More】

  Update: 2026-09-21Source: Haiou HealthViews: 95

• What kind of medicine is Ensartinib?

  Ensartinib is a targeted drug classified as an ALK inhibitor, primarily used for the treatment of ALK fusion-positive locally advanced or metastatic n···【Read More】

  Update: 2026-09-20Source: Haiou HealthViews: 103